“1. This case considers, inter alia, whether the current shortage of judges in the High Court affects the approach of a court to an application to modularise a trial, where that modularisation has the…”
You're reading the free summary of Novartis Pharma AG v Eli Lilly Nederland BV & Ors (Approved). Create a free account to unlock the full reasoning, the cited authorities and the verbatim judgment — plus structured briefs for 412,000+ UK judgments.
No card required. Free forever.
Multiple official and mirror sources — pick whichever loads cleanly on your network.
Falls back to Google for old citations BAILII catalogues separately
Common Room
0 comments · About the Common Room →
No comments yet — start the discussion.
Voted-best comments help future students and feed Caselaw's AI study tools.